OnKure Therapeutics OKUR
NASDAQ OKUR
$2.34 +0.04 (+1.74%)
As of: Oct 22, 2026 · 10:29 AM EDT

OnKure Therapeutics (OKUR) Interest Expenses (2024 - 2025)

Updated

OnKure Therapeutics (OKUR) recorded Interest Expenses of $6,000 in Q4 2025, down 89.5% from $57,000 a year earlier but up 200.0% from the prior quarter.

Analysis

OnKure Therapeutics (OKUR) Interest Expenses (2024 - 2025) Analysis & Trends

For FY2025, OnKure Therapeutics reported Interest Expenses of $8,000, down 97.3% from FY2024.

  • Across earlier years, Interest Expenses came in at $300,000 in FY2024.
  • Quarterly Interest Expenses has ranged from $2,000 in Q3 2025 to $218,000 in Q3 2024 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Eli Lilly 1,164.36 Bn 1,132.95 Bn 19.71 Bn -
2 Johnson & Johnson 634.54 Bn 553.07 Bn 17.26 Bn 281.00 Mn
3 AbbVie 502.85 Bn 475.96 Bn 12.70 Bn -
4 Merck 376.50 Bn 330.88 Bn 12.21 Bn -
5 Novartis Ag 303.65 Bn 267.64 Bn 11.24 Bn 462.00 Mn
6 Astrazeneca 266.62 Bn 240.30 Bn 12.86 Bn 435.00 Mn
7 Amgen 241.17 Bn 196.57 Bn 7.24 Bn 673.00 Mn
8 Gilead Sciences 193.39 Bn 167.59 Bn 6.22 Bn 247.00 Mn
9 Pfizer 172.45 Bn 119.10 Bn 10.94 Bn -
10 OnKure Therapeutics 116.69 Mn -381.23 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 6,000.00
Sep 30, 2025 2,000.00
Dec 31, 2024 57,000.00
Sep 30, 2024 218,000.00
Jun 30, 2024 26,000.00
API Access

OnKure Therapeutics Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=OKUR&period=max&api_key=YOUR_API_KEY